期刊文献+

H型高血压患者发生射血分数保留心力衰竭的危险因素分析 被引量:8

Analysis of risk factors for heart failure with preserved ejection fraction in patients with type H hypertension
下载PDF
导出
摘要 目的探讨H型高血压患者发生射血分数保留心力衰竭(HFpEF)的相关危险因素,为预防HFpEF发生提供参考依据。方法回顾性分析2015年1月至2019年1月于秦皇岛市第一医院心血管内科门诊就诊及住院治疗的200例H型高血压发生HFpEF患者的临床资料,作为研究组,选取同期80例H型高血压合并射血分数正常非心衰患者记为对照组。比较两组患者基本临床信息的差异情况,并采用Logistic逐步回归分析H型高血压患者发生HFpEF的危险因素。结果两组性别构成比、年龄、吸烟史、高血压分级以及合并肥胖症、糖尿病、冠状动脉粥样硬化性心脏病(冠心病)、慢性阻塞性肺疾病(COPD)、心房纤颤(房颤)、睡眠呼吸暂停综合征(SAHS)率比较,差异均有统计学意义(P<0.05),组间左室射血分数(LVEF)、左室舒张末期内径(LVDd)、左室舒张期末室间隔厚度(IVST)、左房容积(LAV)和N末端脑钠肽前体(NT-proBNP)水平比较差异也有统计学意义(P<0.01)。多因素Logistic回归分析显示,女性、高龄、吸烟、高血压Ⅲ级、肥胖症、糖尿病、冠心病、COPD均是H型高血压患者发生HFpEF的危险因素。结论高龄、女性、高血压分级较高及合并肥胖症、糖尿病、冠心病、COPD疾病等因素会增加H型高血压患者发生HFpEF的风险,应结合患者上述因素的具备情况采取相应预防治疗等干预措施,努力降低HFpEF发生风险。 Objective To explore the risk factors of heart failure with preserved ejection fraction(HFpEF)in patients with H-type hypertension,and to provide reference for preventing HFpEF.Methods The clinical data of 200 patients with HFpEF caused by H-type hypertension in the First Hospital of Qinhuangdao from January 2015 to January 2019 were retrospectively analyzed as study group.80 patients with H-type hypertension complicated with normal ejection fraction and non-heart failure in the same period were selected as the control group.The differences in basic clinical information between the two groups of patients were compared,and logistic stepwise regression was used to analyze the risk factors of HFpEF in patients with H-type hypertension.Results There were statistically significant differences in gender composition ratio,age,smoking history,grade of hypertension,and rates of obesity,diabetes,coronary heart disease,COPD,atrial fibrillation,and SAHS between the two groups(P<0.05).The differences in the levels of LVEF,LVDd,IVST,LAV and NT-proBNP between the groups were also statistically significant(P<0.01).Multivariate logistic regression analysis showed that women,old age,smoking,hypertension grade III,obesity,diabetes,coronary heart disease,COPD are all risk factors for HFpEF in patients with type H hypertension.Conclusion The risk of HFpEF in patients with H-type hypertension is increased by factors such as old age,women,high grade of hypertension,obesity,diabetes mellitus,coronary heart disease,COPD disease and so on.The intervention measures such as prevention and treatment should be taken to reduce the risk of HFpEF according to the above factors.
作者 宋婷婷 刘丽 付志强 贾红丹 Song Tingting;Liu Li;Fu Zhiqiang;Jia Hongdan(Department of Cardiology,First Hospital of Qinhuangdao City,Qinhuangdao 066000,China;不详)
出处 《中国循证心血管医学杂志》 2021年第2期194-197,共4页 Chinese Journal of Evidence-Based Cardiovascular Medicine
基金 河北省秦皇岛市重点研发计划科技支撑项目(201805A046)。
关键词 H型高血压 射血分数保留心力衰竭 超声心动图 血清N末端脑钠肽前体 危险因素 H-type hypertension Ejection fraction retention heart failure Echocardiography Serum N-terminal pro-brain natriuretic peptide Risk factors
  • 相关文献

参考文献12

二级参考文献72

  • 1Kannel WB, Castelli WP, McNamara PM, et al. Role of blood pressure in the development of congestive heart failure--the Framingham study [ J ]. N Engl J Med, 1972,287:781-787.
  • 2Levy D, Larson MG, Vasan RS, et al. The progression from hypertension to congestive heart failure [ J ]. JAMA, 1996,275 (20) : 1557 -1562.
  • 3Hsia J, Margolis KL, Eaton CB, et al. Prehyperteasion and cardiovascular disz ease risk in the Women' s Health Initiative[J]. Cireulation,2007,115(7) :855- 860,.
  • 4Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with vari- ous antihypertensive therapies used as first-line agents:a network meta-analysis [ J ]. JAMA,2003,289 (19) :2534-2544.
  • 5Nigel S, Beckett NS, Ruth PR, et al. Treatment of hypertension in patients 80 years age or older[J]. N Engl J Med,2008,358:1887-1898.
  • 6McMurray J J, Adamopeulos S, Anker SD, et al. ESC Guidelines for the diagno- sis and treatment of acute and chronic heart failure 2012:the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Associa- tion(HFA) of the ESC[ J ]. Eur Heart J ,2012,33 (14) : 1787-1847.
  • 7Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Foree on practice guidelines [J].Circulation, 2013,128 ( 16 ) : E240-E327.
  • 8Gonz~ez A, L6pez B, Querejeta R, et al. Filling pressures and collagen metabo- lism in hypertensive patients with heart failure and normal ejection fraction [J]. Hypertension,2010, 55(6) :1418-1424.
  • 9Duulay SM, Roger VL, Weston SA, et 81. Longitudinal changes in ejection frac- tion in heart failure patients with preserved and reduced ejection fraction [J]. Circ Heart Fail ,2012,5 (6) : 720-726.
  • 10Borlang BA, Olson TP, Lam CS, et al. Global cardiovascular reserve dysfunc- tion in heart failure with preserved ejection fraction [ J ]. J Am Con Cardial, 2010,56 ( 11 ) : 845-854.

共引文献137

同被引文献108

引证文献8

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部